Jose Ángel Rodrigo‐Pendás

Jose Ángel Rodrigo‐Pendás

Auto-generated profile, based on publicly available information

Jose Ángel Rodrigo‐Pendás

Servicio de Medicina Preventiva y Epidemiología, Hospital Universitario Vall d'Hebron, Barcelona, España

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2011 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
ETErnesto Trallero-Araguás
Ernesto Trallero-Araguás
JRJose Ángel Rodrigo‐Pendás
Jose Ángel Rodrigo‐Pendás
ASAlbert Selva-O'Callaghan
Albert Selva-O'Callaghan
XMXavier Martínez-Gómez
Xavier Martínez-Gómez
XBXavier Bosch
Xavier Bosch
MVMiquel Vilardell‐Tarrés
Miquel Vilardell‐Tarrés
Objective: Anti‐p155 autoantibody, which was recently described in adult patients with dermatomyositis (DM), seems to be associated with cancer in this population. We performed a systematic review and meta‐analysis to ascertain the accuracy of anti‐p155 testing for the diagnosis of cancer‐associated myositis.Methods: We searched relevant databases, with no restrictions on study design or language, for original studies that included adult patients with probable/definite DM or amyopathic DM who were evaluated for neoplasm and anti‐p155 status. Pooled sensitivity and specificity were calculated using a bivariate model. We computed the diagnostic odds ratio (OR), likelihood ratios (LRs) for positive and negative test results, positive and negative predictive values, and the summary receiver operating characteristic (SROC) curve. Statistical heterogeneity between studies was assessed using the I2 statistic, and 95% confidence intervals (95% CIs) were computed for the parameters studied.Results: Six studies including a total of 312 adult patients with DM were selected. The pooled sensitivity of anti‐p155 for diagnosing cancer‐associated DM was 78% (95% CI 45–94%), and specificity was 89% (95% CI 82–93%). The diagnostic OR was 27.26 (95% CI 6.59–112.82), and LRs for positive and negative test results were 6.79 (95% CI 4.11–11.23) and 0.25 (95% CI 0.08–0.76), respectively. Heterogeneity was substantial except with regard to the LR for a positive test result. The area under the SROC curve was 0.91 (95% CI 0.88–0.93). Taking the pooled prevalence of 17% as pretest probability, anti‐p155 had a positive predictive value of 58% and a negative predictive value of 95%.Conclusion: Our findings indicate that anti‐p155 autoantibody determination is useful for diagnosing cancer‐associated myositis and guiding disease management.

1 April 2017 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
MRMorten Ruhwald
Morten Ruhwald
HAHenrik Aggerbeck
Henrik Aggerbeck
RGRafael Vázquez Gallardo
Rafael Vázquez Gallardo
SHSøren T Hoff
Søren T Hoff
JVJosé I Villate
José I Villate
JCJoan A. Caylà
Joan A. Caylà

23 December 2014 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
YCYolima Cossio‐Gil
Yolima Cossio‐Gil
XMXavier Martínez-Gómez
Xavier Martínez-Gómez
MCMagda Campins‐Martí
Magda Campins‐Martí
RPRodrigo‐ Pendás
Rodrigo‐ Pendás
JÁJosé Ángel
José Ángel
FCFrancesc Casellas‐Jordà
Francesc Casellas‐Jordà

1 June 2016 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
MFMarie Antoinette Frick
Marie Antoinette Frick
HBHector Boix
Hector Boix
FLFátima Camba Longueira
Fátima Camba Longueira
MMM. Teresa Martin-Gomez
M. Teresa Martin-Gomez
JRJosé Ángel Rodrigo-Pendás
José Ángel Rodrigo-Pendás
PSPere Soler-Palacín
Pere Soler-Palacín
Primary cutaneous aspergillosis is rare in premature infants. It requires combined medical and surgical strategies. Liposomal amphotericin B is recommended as first-line therapy, but salvage regimens with others antifungal agents, such as voriconazole, have been reported. Voriconazole’s pharmacodynamics is unknown in this population. We report a case of severe toxicity to voriconazole in a preterm patient with primary cutaneous aspergillosis.

1 December 2014 in Enfermedades Infecciosas y Microbiología Clínica
Verified
Journal Article
Closed access
MFMaría Isabel Fernández-Cano
María Isabel Fernández-Cano
LALluís Armadans-Gil
Lluís Armadans-Gil
MÁMercedes Álvarez-Bartolomé
Mercedes Álvarez-Bartolomé
JRJosé Ángel Rodrigo-Pendás
José Ángel Rodrigo-Pendás
MCMagda Campins-Martí
Magda Campins-Martí

1 May 2003 in Atencion Primaria
Verified
Journal Article
Open access
IGI Rancaño García
I Rancaño García
JPJa Rodrigo Pendás
Ja Rodrigo Pendás
RER Villa Estébanez
R Villa Estébanez
MFM Abdelsater Fayad
M Abdelsater Fayad
RPR Díaz Pérez
R Díaz Pérez
DGD Álvarez García
D Álvarez García